Neoadjuvant Complete Hormonal Blockade Followed by Neoadjuvant Chemotherapy for Resectable Hormone Receptor Positive, HER-2/Neu Negative Breast Cancer, A Phase II Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Exemestane; Methotrexate; Paclitaxel; Triptorelin; Vinorelbine
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jul 2017 Biomarkers information updated
- 05 Oct 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Sep 2007 The expected completion date for this trial is now .